We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Reduced-Antigen, Combined Diphtheria-Tetanus-Acellular Pertussis Vaccine, Adsorbed (Boostrix<sup>®</sup> US Formulation): Use as a Single-Dose Booster Immunization in Adolescents Aged 10-18 Years.
- Authors
Frampton, James E.; Keam, Susan J.
- Abstract
▴ Boostrix® US formulation (hereafter referred to as Tdap) is a formulation of reduced-antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed onto aluminium approved in the US for use as a single-dose booster immunization in adolescents aged 10-18 years. ▴ The diphtheria and tetanus toxoid components of Tdap elicited serologic immune responses comparable to those induced by an approved diphtheria-tetanus (Td) booster vaccine in a large (n = 4114), randomized, observer-blind, multicenter, pivotal trial in US adolescents aged 10-18 years. ▴ In addition, antibody levels against pertussis antigens (pertussis toxoid, filamentous hemagglutinin, and pertactin) induced by Tdap were non-inferior to, and numerically higher than, those induced in infants who completed a three-dose primary immunization course with combined diphtheria-tetanus-acellular pertussis vaccine (Infanrix®), which conferred 89% protection against pertussis. ▴ Tdap had a similar reactogenicity profile, including solicited local reactions and general symptoms, to that of the approved Td vaccine in the pivotal US study. In particular, Tdap was similar (non-inferior) to Td with respect to the primary safety endpoint, namely the incidence of grade 3 pain at the injection site within the 15-day post-vaccination period. ▴ No serious adverse events of potential autoimmune origin or of a new-onset, chronic nature were reported during the 6-month post-vaccination period in the pivotal US study and a smaller (n = 319) German-based trial that also evaluated Tdap.
- Publication
Pediatric Drugs, 2006, Vol 8, Issue 3, p189
- ISSN
1174-5878
- Publication type
Academic Journal
- DOI
10.2165/00148581-200608030-00005